Thermo Fisher Scientific Inc. | Large-cap | Healthcare
$427.76
1.49%
| Thermo Fisher Stock Comparison:
Thermo Fisher vs DanaherThermo Fisher vs Idexx LaboratoriesThermo Fisher vs Agilent TechnologiesThermo Fisher vs Iqvia HoldingsThermo Fisher vs Mettler-ToledoThermo Fisher vs S&P 500 | Market
Overview Income Statement Balance Sheet Cash Flow Key Ratios Peer Comparison

Financial Overview

Latest Annual: 2024

Income Metrics

Revenue 42.9B
Gross Profit 17.7B 41.28%
Operating Income 7.7B 18.00%
Net Income 6.3B 14.78%
EPS (Diluted) $16.53

Balance Sheet Metrics

Total Assets 97.3B
Total Liabilities 47.6B
Shareholders Equity 49.7B
Debt to Equity 0.96

Cash Flow Metrics

Operating Cash Flow 8.7B
Free Cash Flow 7.3B

Revenue & Profitability Trend

Thermo Fisher Income Statement From 2020 to 2024

Metric 2024 2023 2022 2021 2020
Revenue 42.9B 42.9B 44.9B 39.2B 32.2B
Cost of Goods Sold 25.2B 25.8B 25.9B 19.6B 16.2B
Gross Profit 17.7B 17.1B 19.0B 19.6B 16.0B
Operating Expenses 10.0B 9.8B 10.5B 9.4B 8.1B
Operating Income 7.7B 7.3B 8.5B 10.2B 7.9B
Pre-tax Income 7.0B 6.3B 7.8B 8.8B 7.2B
Income Tax 657.0M 284.0M 703.0M 1.1B 850.0M
Net Income 6.3B 6.0B 7.0B 7.7B 6.4B
EPS (Diluted) $16.53 $15.45 $17.63 $19.46 $15.96

Income Statement Trend

Thermo Fisher Balance Sheet From 2020 to 2024

Metric 2024 2023 2022 2021 2020
Assets
Current Assets 22.1B 24.6B 25.2B 20.1B 22.0B
Non-Current Assets 75.2B 74.1B 71.9B 75.0B 47.1B
Total Assets 97.3B 98.7B 97.2B 95.1B 69.1B
Liabilities
Current Liabilities 13.3B 14.0B 17.0B 13.4B 10.3B
Non-Current Liabilities 34.3B 37.9B 36.0B 40.7B 24.2B
Total Liabilities 47.6B 51.9B 53.0B 54.1B 34.5B
Equity
Total Shareholders Equity 49.7B 46.8B 44.1B 41.0B 34.5B

Balance Sheet Composition

Thermo Fisher Cash Flow Statement From 2020 to 2024

Metric 2024 2023 2022 2021 2020
Operating Activities
Net Income 6.3B 6.0B 7.0B 7.7B 6.4B
Operating Cash Flow 8.7B 8.4B 9.1B 8.5B 8.3B
Investing Activities
Capital Expenditures -1.3B -1.4B -2.2B -2.5B -1.5B
Investing Cash Flow -5.8B -5.1B -2.2B -21.9B -1.5B
Financing Activities
Dividends Paid -583.0M -523.0M -455.0M -395.0M -337.0M
Financing Cash Flow -6.8B -5.6B -6.5B 6.6B 376.0M
Free Cash Flow 7.3B 6.9B 6.9B 6.8B 6.8B

Cash Flow Trend

Thermo Fisher Key Financial Ratios

Valuation Ratios

P/E Ratio (TTM) 23.69
Forward P/E 17.19
Price to Book 3.09
Price to Sales 3.55
PEG Ratio 17.19

Profitability Ratios

Profit Margin 15.19%
Operating Margin 17.75%
Return on Equity 13.70%
Return on Assets 5.00%

Financial Health

Current Ratio 1.78
Debt to Equity 69.23
Beta 0.78

Per Share Data

EPS (TTM) $17.05
Book Value per Share $130.84
Revenue per Share $112.59

Peer Financial Comparison

Company Market Cap P/E Ratio P/B Ratio ROE Profit Margin Debt/Equity
tmo 152.5B 23.69 3.09 13.70% 15.19% 69.23
Danaher 140.5B 37.98 2.76 7.22% 15.81% 34.56
Idexx Laboratories 42.1B 48.33 29.21 59.33% 22.76% 73.16
Agilent Technologies 33.0B 28.60 5.37 18.88% 17.59% 60.04
Iqvia Holdings 27.4B 21.64 4.61 21.64% 8.61% 242.91
Mettler-Toledo 24.0B 28.82 -135.91 -680.23% 22.17% -11.40

Financial data is updated regularly. All figures are in the company's reporting currency.